HPA026631

antibody from Atlas Antibodies

Targeting: NCAPG2 CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

HPA026631

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA026631, RRID:AB_1845983

Product name

Anti-NCAPG2

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human NCAPG2, Gene description: non-SMC condensin II complex, subunit G2, Alternative Gene Names: CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB, Validated applications: ICC, IHC, Uniprot ID: Q86XI2, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.2 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins

Yuan L, Li J, Yang Y, Chen Y, Ma T, Liang S, Bu Y, Yu L, Nan Y
World Journal of Gastroenterology 2021;27(16):1785-1804

---

Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma

Ye L, Wang H, Li H, Liu H, Lv T, Song Y, Zhang F
Journal of Cancer 2019;10(4):1032-1038

---

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma

Zhan P, Xi G, Zhang B, Wu Y, Liu H, Liu Y, Xu W, Zhu Q, Cai F, Zhou Z, Miu Y, Wang X, Jin J, Li Q, Lv T, Song Y
Journal of Cellular and Molecular Medicine 2016;21(4):665-676